@article{41e27dbfc8ce410e96f4864c2e9a5f7e,
title = "Patient-reported and Cost-effectiveness Outcomes Are Key to Determining the Optimal Therapeutic Sequence for Patients with Metastatic Renal Cell Carcinoma",
keywords = "Carcinoma, Renal Cell, Cost-Benefit Analysis, Humans, Kidney Neoplasms, Neoplasms, Second Primary, Quality-Adjusted Life Years",
author = "Ristau, {Benjamin T.} and Geynisman, {Daniel M.}",
year = "2017",
month = feb,
day = "1",
doi = "10.1016/j.eururo.2016.09.003",
language = "English",
volume = "71",
pages = "210--212",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "2",
}